SUBSCRIBE
SUBSCRIBE
News   FDA

AstraZeneca PLC (JOBS), Bristol-Myers Squibb Company (JOBS) Diabetes Drug Onglyza Wins U.S. OK

July 31, 2009 | 
1 min read

WASHINGTON, July 31 (Reuters) - AstraZeneca PLC (AZN.L) and Bristol-Myers Squibb Co (BMY.N) won U.S. approval on Friday to sell a new diabetes drug called Onglyza.

FDA Approvals
AstraZeneca Pharmaceuticals LP Bristol Myers Squibb Company
MORE ON THIS TOPIC
Successful businessman standing in front of multiple pathways, making a decision for the right move. A symbol of great investment and positive progress in the development of business. stock illustration
Mergers & acquisitions
Lilly-Verve Proxy Filing Reveals Tumult After Departure of FDA’s Marks
June 26, 2025
 · 
4 min read
 · 
Annalee Armstrong
FDA Headquarters_Grandbrothers/Adobe Stock
Policy
Former CBER Chief Marks Decries New FDA COVID-19 Framework
June 26, 2025
 · 
3 min read
 · 
Tristan Manalac
Finding Talent. Big Hands with Magnifying Glass Recruiting People. vector
Duchenne muscular dystrophy
FDA Reviews Sarepta’s Elevidys After Second Patient Death
June 25, 2025
 · 
2 min read
 · 
Tristan Manalac
Washington, D.C., USA- January 13, 2020: FDA Sign at its headquarters in Washington DC. The Food and Drug Administration (FDA or USFDA) is a federal agency of the USA.
FDA
FDA Names Psychedelic Proponent as CDER Deputy Director, Top Spot Remains Open
June 25, 2025
 · 
2 min read
 · 
Tristan Manalac